EV/EBITDA
-1.20
+0.16+11.76%
1 min ago
Summary
- As of March 10, 2025, TNGX EV/EBITDA is -1.20, with a rise of +0.16 (+11.76%) during the most recent trading day.
- Over the past year, TNGX EV/EBITDA has increased by +9.02 (+88.26%).
- TNGX EV/EBITDA is now -3.45% below its all-time high of -1.16.
Performance
TNGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TNGX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +11.8% | -11.9% | -10.2% |
| 1 m1 month | +34.1% | -34.2% | -30.6% |
| 3 m3 months | +48.7% | -48.8% | -44.8% |
| 6 m6 months | +83.0% | -81.3% | -78.2% |
| ytdytd | +43.7% | -43.7% | -39.6% |
| 1 y1 year | +88.3% | -85.0% | -83.4% |
| 5 y5 years | - | - | - |
TNGX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.5% | -2.08 | +42.3% | |
| 3 m | 3-month | -1.16 | -3.5% | -2.43 | +50.6% |
| 6 m | 6-month | -1.16 | -3.5% | -8.81 | +86.4% |
| 1 y | 1-year | -1.16 | -3.5% | -10.22 | +88.3% |
| 3 y | 3-year | -1.16 | -3.5% | -11.79 | +89.8% |
| 5 y | 5-year | -1.16 | -3.5% | -23.77 | +95.0% |
| alltime | all time | -1.16 | -3.5% | -23.77 | +95.0% |
Tango Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.20(-43.7%) |
| 2024 | -2.13(-75.8%) |
| Date | Value |
|---|---|
| 2023 | -8.81(+55.4%) |
| 2022 | -5.67(-60.2%) |
| 2021 | -14.26 |
FAQ
- What is Tango Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Tango Therapeutics?
- What is TNGX EV/EBITDA year-to-date change?
- What is Tango Therapeutics EV/EBITDA year-on-year change?
What is Tango Therapeutics EV/EBITDA?
The current EV/EBITDA of TNGX is -1.20
What is the all time high EV/EBITDA for Tango Therapeutics?
Tango Therapeutics all-time high EV/EBITDA is -1.16
What is TNGX EV/EBITDA year-to-date change?
Tango Therapeutics EV/EBITDA has changed by +0.93 (+43.66%) since the beginning of the year
What is Tango Therapeutics EV/EBITDA year-on-year change?
Over the past year, TNGX EV/EBITDA has changed by +9.02 (+88.26%)